Trial Profile
Clinical trial with NaPPS for HTLV-1-associated myelopathy (HAM) patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Pentosan polysulfate (Primary)
- Indications Spinal cord disorders
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors ReqMed
- 05 Nov 2014 New trial record